6 Jan 2020 shares of Arbutus Biopharma Corporation (NASDAQ:ABUS) marked You Should Buy Arbutus Biopharma Corporation (ABUS) Stock? Ad. 17 Jan 2020 Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and Get Arbutus Biopharma Corp (ABUS:NASDAQ) real-time stock quotes, news and financial information from CNBC. See Arbutus Biopharma price target based on 2 analysts offering 12 month price targets for Arbutus Biopharma in the last 3 months. The average price target is Technical stock forecast for ABUS: The Arbutus Biopharma Corporation stock holds several negative signals and despite the positive trend we believe Arbutus Jan-02-20 05:05AM, Does The Arbutus Biopharma Corporation (NASDAQ:ABUS) Share Price Tend To Follow The Market? Simply Wall St. +5.76%. Dec-30-19 View the latest Arbutus Biopharma Corp. (ABUS) stock price, news, historical charts, analyst ratings and financial information from WSJ.
11 hours ago · Technical chart claims that Arbutus Biopharma Corporation (ABUS) would settle between $3.09/share to $3.22/share level. However, if the stock price goes below the $2.87 mark, then the market for Arbutus Biopharma Corporation becomes much weaker. If that happens, the stock price might even plunge as low as $2.78 for its downside target. Why Arbutus Biopharma Stock Plunged 24.4% Today - Market Oct 09, 2018 · Today, Arbutus Biopharma (ABUS) stock is trading at $6.87, which is a 24.42% decline from its October 8 closing price of $9.09. Arbutus Biopharma’s … ABUS - Arbutus Biopharma Cp Stock Barchart Opinion
Get breaking news and analysis on Arbutus Biopharma Corporation (ABUS) stock, price quote and chart, trading and investing tools. ABUS: Get the latest Arbutus Biopharma stock price and detailed information including ABUS news, historical charts and realtime prices. View Arbutus Biopharma Corporation ABUS investment & stock information. Arbutus Biopharma Corporation (ABUS). (Delayed Data from NSDQ). $2.89 USD. ARBUTUS BIOPHARMA CORPORATION (NASDAQ:ABUS) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ARBUTUS BIOPHARMA Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. ARBUTUS BIOPHARMA quote : historical data and live quotes, charts, news, analyses, trading signals, calendar, informations and community tools. Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering
ABUS - Arbutus Biopharma Cp Stock Price - Barchart.com Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Andrew Cheng, …
Real-time trade and investing ideas on Arbutus Biopharma Corporation ABUS from the largest community of traders and investors. 7 Jan 2020 It is a pleasure to report that the Arbutus Biopharma Corporation Even the share prices of good stocks drop sometimes, but we want to see View Arbutus Biopharma Corporation ABUS investment & stock information. Get the latest Arbutus Biopharma Corporation ABUS detailed stock quotes, stock ABUS: Get the latest Arbutus Biopharma stock price and detailed information including ABUS news, historical charts and realtime prices. View today's stock price, news and analysis for Arbutus Biopharma Corp. (ABUS). Barron's also provides information on historical stock ratings, target prices, Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 1.25, with a high estimate of 6.00 and